BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG) announced today the appointment of Philip A. Incarnati to the Company’s Board of Directors. Mr. Incarnati has also been appointed to the Audit Committee of the Board of Directors.
